Latest Breaking News On - Juan alderuccio - Page 1 : comparemela.com

Recent Approvals Across Hematologic Malignancies Usher in a New Era

Mikkael A. Sekeres, MD, MS, highlights recent approvals and emerging therapeutics in hematologic malignancies discussed by his colleagues.

University of miamiUnited statesTerrencej bradleyMikkaela sekeresAlvaro alencarJuan alderuccioInternational prognostic indexUniversity of miami health systemSylvester comprehensive cancer centerDivision of hematologyOnclive stateScience summitLeukemia sectionMiami health systemHematologic malignanciesMikkaela sekeres

Bispecific Antibodies Change the Landscape of Lymphoma Treatment

Experts look back on the year in the news regarding bispecific antibodies for the treatment of B-cell lymphomas including CLL and SLL.

Juan alderuccioLee greenbergerDrug administrationUniversity of miami sylvester comprehensive cancer centerLymphoma societyMiami sylvester comprehensive cancer centerNew horizonsDiffuse largeb cellSpeaking out

Jaypirca, Much-Needed Treatment for CLL and SLL, Approved by FDA

Recently approved by the FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), Jaypirca “represents a meaningful advance” in treatment, as one expert explained.

Adam kittaiJuan alderuccioJames cancer centerDrug administrationOhio university cancer centerSylvester comprehensive cancer centerUniversity of miami health systemMiami health systemEducated patient

Study describes treatment of secondary CNS involvement by aggressive lymphomas

Study describes treatment of secondary CNS involvement by aggressive lymphomas
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesJuan alderuccioGabriel caponettiJuan pablo alderuccioSylvester comprehensive cancer centerUniversity of miami miller school medicineMiami miller school